[NEJM] Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism

JJappy Post time Yesterday 20:05 | Show all posts |Read mode
This post will be closed automatically in 2026-08-02 20:05
Reward10points

journalㄩNew England Journal of Medicine

AuthorsㄩLana A. Castellucci; Vivien M. Chen; Michael J. Kovacs; Alejandro Lazo-Langner; Peter Greenstreet; Susan Kahn; Benoit Ct谷; Sam Schulman; Kerstin de Wit; James Douketis; Deepa Suryanarayan; Tony Wan; Erik Yeo; Genevieve Le Templier; Huyen A. Tran; Abbey Willcox; Helen J. Crowther; Ritam Prasad; Sudeep Shivakumar; Etimbuk Umana; Fionnuala Ni Ainle; Tobias Tritschler; Stefano Barco; Jean-Philippe Galanaud; Marc Blondon; Lisa Baumann Kreuziger; Susan Solymoss; Clive Kearon; Erin Thomas; Tim Ramsay; Gregoire Le Gal; Marc Rodger

Published dateㄩ2026-3-12

DOIㄩ10.1056/nejmoa2510703

PDF linkㄩhttp://www.nejm.org/doi/pdf/10.1056/NEJMoa2510703

Article linkㄩhttps://doi.org/10.1056/nejmoa2510703

Article SourceㄩMassachusetts Medical Society


Remarkㄩ

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
Georgee Post time Yesterday 20:05 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Return to the list